Review



se r d systems  (R&D Systems)


Bioz Verified Symbol R&D Systems is a verified supplier
Bioz Manufacturer Symbol R&D Systems manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 91

    Structured Review

    R&D Systems se r d systems
    Se R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+mouse+plasminogen+activator/Recombinant+Mouse+u-Plasminogen+Activator+(uPA)+Protein%2C+CF/pm38113659-50-8-9
    Average 91 stars, based on 1 article reviews
    se r d systems - by Bioz Stars, 2026-10
    91/100 stars

    Images

    Related Articles

    Recombinant:

    Article Title: Decreased fertility in female mice lacking urokinase plasminogen activator.
    Article Snippet: .. Recombinant Mouse Plasminogen Activator (uPA)/Urokinase His-tag Catalog Number: 11143-SE R&D Systems. ..



    Similar Products

    93
    Cusabio recombinant mouse serpine1
    Recombinant Mouse Serpine1, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+mouse+plasminogen+activator/Recombinant+Mouse+Plasminogen+activator+inhibitor+1/10__1016_slash_j__jhazmat__2025__137116-60-0-7
    Average 93 stars, based on 1 article reviews
    recombinant mouse serpine1 - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    93
    Boster Bio mouse plau elisa kit
    <t>PLAU</t> derived from SCAFs promotes PDAC progression in vitro and in vivo (A) Relative mRNA expression of genes in human CAFs treated with 400 μM H 2 O 2 was measured by qRT-PCR. (B) The mRNA expression levels of genes in various cell types in the TME of PDAC. (C) The relationship between PLAU expression and UCell senescence score in CAFs. (D) PLAU knockdown in human SCAFs was verified by <t>ELISA.</t> (E) The migration and invasion abilities of the indicated cells were assessed by Transwell assay. Scale bar, 20 μm. (F) PLAU overexpression in human CAFs was verified by ELISA. (G) The migration and invasion abilities of the indicated cells were assessed by Transwell assay. Scale bar, 20 μm. (H) The flow of the experimental design. (I) Bioluminescence images showing orthotopically transplanted PDAC tumors. (J) Photographs and volumes of tumors. (K and L) Representative flow cytometry images and statistical analysis of CD3 + (K) and CD8 + T cells (L) in tumors in different groups. (M and N) Representative flow cytometry images and statistical analysis of MDSCs (M) and M2 macrophage (N) in tumors in different groups. Data are represented as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Mouse Plau Elisa Kit, supplied by Boster Bio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+mouse+plasminogen+activator/Human+u-Plasminogen+Activator%2FUrokinase+Recombinant+Protein/pmc11742819-489-6-13
    Average 93 stars, based on 1 article reviews
    mouse plau elisa kit - by Bioz Stars, 2026-10
    93/100 stars
      Buy from Supplier

    90
    Cusabio sch79797 par 1 inhibitor dba
    <t>PLAU</t> derived from SCAFs promotes PDAC progression in vitro and in vivo (A) Relative mRNA expression of genes in human CAFs treated with 400 μM H 2 O 2 was measured by qRT-PCR. (B) The mRNA expression levels of genes in various cell types in the TME of PDAC. (C) The relationship between PLAU expression and UCell senescence score in CAFs. (D) PLAU knockdown in human SCAFs was verified by <t>ELISA.</t> (E) The migration and invasion abilities of the indicated cells were assessed by Transwell assay. Scale bar, 20 μm. (F) PLAU overexpression in human CAFs was verified by ELISA. (G) The migration and invasion abilities of the indicated cells were assessed by Transwell assay. Scale bar, 20 μm. (H) The flow of the experimental design. (I) Bioluminescence images showing orthotopically transplanted PDAC tumors. (J) Photographs and volumes of tumors. (K and L) Representative flow cytometry images and statistical analysis of CD3 + (K) and CD8 + T cells (L) in tumors in different groups. (M and N) Representative flow cytometry images and statistical analysis of MDSCs (M) and M2 macrophage (N) in tumors in different groups. Data are represented as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Sch79797 Par 1 Inhibitor Dba, supplied by Cusabio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+mouse+plasminogen+activator/Recombinant+Mouse+Plasminogen+activator+inhibitor+1/ppr0929131-444-18-26
    Average 90 stars, based on 1 article reviews
    sch79797 par 1 inhibitor dba - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    91
    R&D Systems se r d systems
    <t>PLAU</t> derived from SCAFs promotes PDAC progression in vitro and in vivo (A) Relative mRNA expression of genes in human CAFs treated with 400 μM H 2 O 2 was measured by qRT-PCR. (B) The mRNA expression levels of genes in various cell types in the TME of PDAC. (C) The relationship between PLAU expression and UCell senescence score in CAFs. (D) PLAU knockdown in human SCAFs was verified by <t>ELISA.</t> (E) The migration and invasion abilities of the indicated cells were assessed by Transwell assay. Scale bar, 20 μm. (F) PLAU overexpression in human CAFs was verified by ELISA. (G) The migration and invasion abilities of the indicated cells were assessed by Transwell assay. Scale bar, 20 μm. (H) The flow of the experimental design. (I) Bioluminescence images showing orthotopically transplanted PDAC tumors. (J) Photographs and volumes of tumors. (K and L) Representative flow cytometry images and statistical analysis of CD3 + (K) and CD8 + T cells (L) in tumors in different groups. (M and N) Representative flow cytometry images and statistical analysis of MDSCs (M) and M2 macrophage (N) in tumors in different groups. Data are represented as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Se R D Systems, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+mouse+plasminogen+activator/Recombinant+Mouse+u-Plasminogen+Activator+(uPA)+Protein%2C+CF/pm38113659-50-8-9
    Average 91 stars, based on 1 article reviews
    se r d systems - by Bioz Stars, 2026-10
    91/100 stars
      Buy from Supplier

    91
    R&D Systems recombinant mouse plasminogen activator
    <t>PLAU</t> derived from SCAFs promotes PDAC progression in vitro and in vivo (A) Relative mRNA expression of genes in human CAFs treated with 400 μM H 2 O 2 was measured by qRT-PCR. (B) The mRNA expression levels of genes in various cell types in the TME of PDAC. (C) The relationship between PLAU expression and UCell senescence score in CAFs. (D) PLAU knockdown in human SCAFs was verified by <t>ELISA.</t> (E) The migration and invasion abilities of the indicated cells were assessed by Transwell assay. Scale bar, 20 μm. (F) PLAU overexpression in human CAFs was verified by ELISA. (G) The migration and invasion abilities of the indicated cells were assessed by Transwell assay. Scale bar, 20 μm. (H) The flow of the experimental design. (I) Bioluminescence images showing orthotopically transplanted PDAC tumors. (J) Photographs and volumes of tumors. (K and L) Representative flow cytometry images and statistical analysis of CD3 + (K) and CD8 + T cells (L) in tumors in different groups. (M and N) Representative flow cytometry images and statistical analysis of MDSCs (M) and M2 macrophage (N) in tumors in different groups. Data are represented as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.
    Recombinant Mouse Plasminogen Activator, supplied by R&D Systems, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+mouse+plasminogen+activator/Recombinant+Mouse+u-Plasminogen+Activator+(uPA)+Protein%2C+CF/pm38113659-50-0-9
    Average 91 stars, based on 1 article reviews
    recombinant mouse plasminogen activator - by Bioz Stars, 2026-10
    91/100 stars
      Buy from Supplier

    90
    Cusabio huvecs
    Figure 6. Age-dependent changes of fibroblast function on endothelial cells. (A and B) Experimental outline and tube formation assay of human umbilical vein endothelial cells <t>(HUVECs)</t> that were cultured in conditioned medium received from young (12 weeks) and aged (20 months) cardiac mouse fibroblasts. Accumulated tube length was measured in 5 randomly chosen microscopic fields with a computer-assisted microscope using Axiovision 4.5 (Zeiss) (scale bar: 100 μm; n = 4). (C) Capillary density of random healthy areas of young (12 weeks; n = 6) and old (n = 8) heart sections versus capillary density of fibrotic (n = 8) areas of aged hearts (20 months). Shown is the quantification of the Isolectin B4–positive area versus the total area (%). (D) Expression of Serpine1, Serpine2, and Efemp1 in fibroblasts displayed in log scale in trajectory plots. (E) Secretion of SerpinE1 in isolated young and aged cardiac fibroblasts cultured for 24 hours in serum-free medium. Data were derived using a mouse angiogenesis array (R&D Systems) of culture supernatants of isolated cardiac fibroblasts (n = 4). (F) Tube formation assay of HUVECs that were cultured in conditioned medium received from young (12 weeks) and aged (20 months) cardiac mouse fibroblasts. The aged phenotype was rescued by supplementing the aged fibroblast medium with 4 μg of <t>an</t> <t>anti-Serpin</t> antibody. Accumulated tube length was mea- sured in 5 randomly chosen microscopic fields with a computer-assisted microscope using Axiovision 4.5 (Zeiss) (scale bar: 200 μm; n = 4). (G) RNA expression
    Huvecs, supplied by Cusabio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+mouse+plasminogen+activator/Recombinant+Mouse+Plasminogen+activator+inhibitor+1/pm31723062-336-5-17
    Average 90 stars, based on 1 article reviews
    huvecs - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    90
    Cusabio serpin e1
    Figure 6. Age-dependent changes of fibroblast function on endothelial cells. (A and B) Experimental outline and tube formation assay of human umbilical vein endothelial cells (HUVECs) that were cultured in conditioned medium received from young (12 weeks) and aged (20 months) cardiac mouse fibroblasts. Accumulated tube length was measured in 5 randomly chosen microscopic fields with a computer-assisted microscope using Axiovision 4.5 (Zeiss) (scale bar: 100 μm; n = 4). (C) Capillary density of random healthy areas of young (12 weeks; n = 6) and old (n = 8) heart sections versus capillary density of fibrotic (n = 8) areas of aged hearts (20 months). Shown is the quantification of the Isolectin B4–positive area versus the total area (%). (D) Expression of Serpine1, Serpine2, and Efemp1 in fibroblasts displayed in log scale in trajectory plots. (E) Secretion of SerpinE1 in isolated young and aged cardiac fibroblasts cultured for 24 hours in serum-free medium. Data were derived using a mouse angiogenesis array (R&D Systems) of culture supernatants of isolated cardiac fibroblasts (n = 4). (F) Tube formation assay of HUVECs that were cultured in conditioned medium received from young (12 weeks) and aged (20 months) cardiac mouse fibroblasts. The aged phenotype was rescued by supplementing the aged fibroblast medium with 4 μg of an <t>anti-Serpin</t> antibody. Accumulated tube length was mea- sured in 5 randomly chosen microscopic fields with a computer-assisted microscope using Axiovision 4.5 (Zeiss) (scale bar: 200 μm; n = 4). (G) RNA expression
    Serpin E1, supplied by Cusabio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/recombinant+mouse+plasminogen+activator/Recombinant+Mouse+Plasminogen+activator+inhibitor+1/pm31723062-336-14-17
    Average 90 stars, based on 1 article reviews
    serpin e1 - by Bioz Stars, 2026-10
    90/100 stars
      Buy from Supplier

    Image Search Results


    PLAU derived from SCAFs promotes PDAC progression in vitro and in vivo (A) Relative mRNA expression of genes in human CAFs treated with 400 μM H 2 O 2 was measured by qRT-PCR. (B) The mRNA expression levels of genes in various cell types in the TME of PDAC. (C) The relationship between PLAU expression and UCell senescence score in CAFs. (D) PLAU knockdown in human SCAFs was verified by ELISA. (E) The migration and invasion abilities of the indicated cells were assessed by Transwell assay. Scale bar, 20 μm. (F) PLAU overexpression in human CAFs was verified by ELISA. (G) The migration and invasion abilities of the indicated cells were assessed by Transwell assay. Scale bar, 20 μm. (H) The flow of the experimental design. (I) Bioluminescence images showing orthotopically transplanted PDAC tumors. (J) Photographs and volumes of tumors. (K and L) Representative flow cytometry images and statistical analysis of CD3 + (K) and CD8 + T cells (L) in tumors in different groups. (M and N) Representative flow cytometry images and statistical analysis of MDSCs (M) and M2 macrophage (N) in tumors in different groups. Data are represented as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Journal: iScience

    Article Title: Revealing the role of cancer-associated fibroblast senescence in prognosis and immune landscape in pancreatic cancer

    doi: 10.1016/j.isci.2024.111612

    Figure Lengend Snippet: PLAU derived from SCAFs promotes PDAC progression in vitro and in vivo (A) Relative mRNA expression of genes in human CAFs treated with 400 μM H 2 O 2 was measured by qRT-PCR. (B) The mRNA expression levels of genes in various cell types in the TME of PDAC. (C) The relationship between PLAU expression and UCell senescence score in CAFs. (D) PLAU knockdown in human SCAFs was verified by ELISA. (E) The migration and invasion abilities of the indicated cells were assessed by Transwell assay. Scale bar, 20 μm. (F) PLAU overexpression in human CAFs was verified by ELISA. (G) The migration and invasion abilities of the indicated cells were assessed by Transwell assay. Scale bar, 20 μm. (H) The flow of the experimental design. (I) Bioluminescence images showing orthotopically transplanted PDAC tumors. (J) Photographs and volumes of tumors. (K and L) Representative flow cytometry images and statistical analysis of CD3 + (K) and CD8 + T cells (L) in tumors in different groups. (M and N) Representative flow cytometry images and statistical analysis of MDSCs (M) and M2 macrophage (N) in tumors in different groups. Data are represented as mean ± SD. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001.

    Article Snippet: The Human PLAU ELISA Kit and Mouse PLAU ELISA kit were purchased from BOSTER (Wuhan, China) and Hengyuan Biological Technology (Shanghai, China).

    Techniques: Derivative Assay, In Vitro, In Vivo, Expressing, Quantitative RT-PCR, Knockdown, Enzyme-linked Immunosorbent Assay, Migration, Transwell Assay, Over Expression, Flow Cytometry

    Journal: iScience

    Article Title: Revealing the role of cancer-associated fibroblast senescence in prognosis and immune landscape in pancreatic cancer

    doi: 10.1016/j.isci.2024.111612

    Figure Lengend Snippet:

    Article Snippet: The Human PLAU ELISA Kit and Mouse PLAU ELISA kit were purchased from BOSTER (Wuhan, China) and Hengyuan Biological Technology (Shanghai, China).

    Techniques: Purification, Blocking Assay, Virus, Plasmid Preparation, Recombinant, Saline, Staining, Marker, Bicinchoninic Acid Protein Assay, CCK-8 Assay, Infection, Enzyme-linked Immunosorbent Assay, Gene Expression, Microarray, Expressing, Software

    Figure 6. Age-dependent changes of fibroblast function on endothelial cells. (A and B) Experimental outline and tube formation assay of human umbilical vein endothelial cells (HUVECs) that were cultured in conditioned medium received from young (12 weeks) and aged (20 months) cardiac mouse fibroblasts. Accumulated tube length was measured in 5 randomly chosen microscopic fields with a computer-assisted microscope using Axiovision 4.5 (Zeiss) (scale bar: 100 μm; n = 4). (C) Capillary density of random healthy areas of young (12 weeks; n = 6) and old (n = 8) heart sections versus capillary density of fibrotic (n = 8) areas of aged hearts (20 months). Shown is the quantification of the Isolectin B4–positive area versus the total area (%). (D) Expression of Serpine1, Serpine2, and Efemp1 in fibroblasts displayed in log scale in trajectory plots. (E) Secretion of SerpinE1 in isolated young and aged cardiac fibroblasts cultured for 24 hours in serum-free medium. Data were derived using a mouse angiogenesis array (R&D Systems) of culture supernatants of isolated cardiac fibroblasts (n = 4). (F) Tube formation assay of HUVECs that were cultured in conditioned medium received from young (12 weeks) and aged (20 months) cardiac mouse fibroblasts. The aged phenotype was rescued by supplementing the aged fibroblast medium with 4 μg of an anti-Serpin antibody. Accumulated tube length was mea- sured in 5 randomly chosen microscopic fields with a computer-assisted microscope using Axiovision 4.5 (Zeiss) (scale bar: 200 μm; n = 4). (G) RNA expression

    Journal: JCI insight

    Article Title: Transcriptional heterogeneity of fibroblasts is a hallmark of the aging heart.

    doi: 10.1172/jci.insight.131092

    Figure Lengend Snippet: Figure 6. Age-dependent changes of fibroblast function on endothelial cells. (A and B) Experimental outline and tube formation assay of human umbilical vein endothelial cells (HUVECs) that were cultured in conditioned medium received from young (12 weeks) and aged (20 months) cardiac mouse fibroblasts. Accumulated tube length was measured in 5 randomly chosen microscopic fields with a computer-assisted microscope using Axiovision 4.5 (Zeiss) (scale bar: 100 μm; n = 4). (C) Capillary density of random healthy areas of young (12 weeks; n = 6) and old (n = 8) heart sections versus capillary density of fibrotic (n = 8) areas of aged hearts (20 months). Shown is the quantification of the Isolectin B4–positive area versus the total area (%). (D) Expression of Serpine1, Serpine2, and Efemp1 in fibroblasts displayed in log scale in trajectory plots. (E) Secretion of SerpinE1 in isolated young and aged cardiac fibroblasts cultured for 24 hours in serum-free medium. Data were derived using a mouse angiogenesis array (R&D Systems) of culture supernatants of isolated cardiac fibroblasts (n = 4). (F) Tube formation assay of HUVECs that were cultured in conditioned medium received from young (12 weeks) and aged (20 months) cardiac mouse fibroblasts. The aged phenotype was rescued by supplementing the aged fibroblast medium with 4 μg of an anti-Serpin antibody. Accumulated tube length was mea- sured in 5 randomly chosen microscopic fields with a computer-assisted microscope using Axiovision 4.5 (Zeiss) (scale bar: 200 μm; n = 4). (G) RNA expression

    Article Snippet: For the recombinant serpin study, HUVECs were cultured in medium supplemented with 10 ng/mL serpin E1 (CSB-EP021081MO, Cusabio) or serpin E2 (2175-PI-010, R&D Systems) for 24 hours.

    Techniques: Tube Formation Assay, Cell Culture, Microscopy, Expressing, Isolation, Derivative Assay, RNA Expression

    Figure 6. Age-dependent changes of fibroblast function on endothelial cells. (A and B) Experimental outline and tube formation assay of human umbilical vein endothelial cells (HUVECs) that were cultured in conditioned medium received from young (12 weeks) and aged (20 months) cardiac mouse fibroblasts. Accumulated tube length was measured in 5 randomly chosen microscopic fields with a computer-assisted microscope using Axiovision 4.5 (Zeiss) (scale bar: 100 μm; n = 4). (C) Capillary density of random healthy areas of young (12 weeks; n = 6) and old (n = 8) heart sections versus capillary density of fibrotic (n = 8) areas of aged hearts (20 months). Shown is the quantification of the Isolectin B4–positive area versus the total area (%). (D) Expression of Serpine1, Serpine2, and Efemp1 in fibroblasts displayed in log scale in trajectory plots. (E) Secretion of SerpinE1 in isolated young and aged cardiac fibroblasts cultured for 24 hours in serum-free medium. Data were derived using a mouse angiogenesis array (R&D Systems) of culture supernatants of isolated cardiac fibroblasts (n = 4). (F) Tube formation assay of HUVECs that were cultured in conditioned medium received from young (12 weeks) and aged (20 months) cardiac mouse fibroblasts. The aged phenotype was rescued by supplementing the aged fibroblast medium with 4 μg of an anti-Serpin antibody. Accumulated tube length was mea- sured in 5 randomly chosen microscopic fields with a computer-assisted microscope using Axiovision 4.5 (Zeiss) (scale bar: 200 μm; n = 4). (G) RNA expression

    Journal: JCI insight

    Article Title: Transcriptional heterogeneity of fibroblasts is a hallmark of the aging heart.

    doi: 10.1172/jci.insight.131092

    Figure Lengend Snippet: Figure 6. Age-dependent changes of fibroblast function on endothelial cells. (A and B) Experimental outline and tube formation assay of human umbilical vein endothelial cells (HUVECs) that were cultured in conditioned medium received from young (12 weeks) and aged (20 months) cardiac mouse fibroblasts. Accumulated tube length was measured in 5 randomly chosen microscopic fields with a computer-assisted microscope using Axiovision 4.5 (Zeiss) (scale bar: 100 μm; n = 4). (C) Capillary density of random healthy areas of young (12 weeks; n = 6) and old (n = 8) heart sections versus capillary density of fibrotic (n = 8) areas of aged hearts (20 months). Shown is the quantification of the Isolectin B4–positive area versus the total area (%). (D) Expression of Serpine1, Serpine2, and Efemp1 in fibroblasts displayed in log scale in trajectory plots. (E) Secretion of SerpinE1 in isolated young and aged cardiac fibroblasts cultured for 24 hours in serum-free medium. Data were derived using a mouse angiogenesis array (R&D Systems) of culture supernatants of isolated cardiac fibroblasts (n = 4). (F) Tube formation assay of HUVECs that were cultured in conditioned medium received from young (12 weeks) and aged (20 months) cardiac mouse fibroblasts. The aged phenotype was rescued by supplementing the aged fibroblast medium with 4 μg of an anti-Serpin antibody. Accumulated tube length was mea- sured in 5 randomly chosen microscopic fields with a computer-assisted microscope using Axiovision 4.5 (Zeiss) (scale bar: 200 μm; n = 4). (G) RNA expression

    Article Snippet: For the recombinant serpin study, HUVECs were cultured in medium supplemented with 10 ng/mL serpin E1 (CSB-EP021081MO, Cusabio) or serpin E2 (2175-PI-010, R&D Systems) for 24 hours.

    Techniques: Tube Formation Assay, Cell Culture, Microscopy, Expressing, Isolation, Derivative Assay, RNA Expression